{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:31:26Z","timestamp":1790303486829,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2016.00290","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T03:47:33Z","timestamp":1480391253000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Dawei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/WNL.0000000000003085","article-title":"Neurofilament light chain level is a weak risk factor for the development of MS.","volume":"87","author":"Arrambide","year":"2016","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","article-title":"Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.","volume":"84","author":"Boylan","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS.","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"issue":"173","key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0689-x","article-title":"Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1468-1331.2009.02853.x","article-title":"Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.","volume":"17","author":"Fialova","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"e75091","key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/21678421.2012.729596","article-title":"pNfH is a promising biomarker for ALS.","volume":"14","author":"Ganesalingam","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J. Neurochem."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1212894","article-title":"Phosphoneurofilament heavy chain and vascular endothelial growth factor as cerebrospinal fluid biomarkers for ALS.","author":"Goncalves","year":"2016","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cca.2014.09.011","article-title":"Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.","volume":"438","author":"Goncalves","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchemneu.2016.05.006","article-title":"The axon as a physical structure in health and acute trauma.","volume":"76","author":"Kirkcaldie","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ana.22438","article-title":"The neurofilament light chain is not stable in vitro.","volume":"69","author":"Koel-Simmelink","year":"2011","journal-title":"Ann. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jim.2013.11.008","article-title":"The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.","volume":"402","author":"Koel-Simmelink","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneuroim.2010.01.004","article-title":"A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein.","volume":"220","author":"Kuhle","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/21678421.2014.884592","article-title":"Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.","volume":"15","author":"Lehnert","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jns.2016.05.062","article-title":"Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.","volume":"367","author":"Li","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ane.12157","article-title":"Age at onset of amyotrophic lateral sclerosis in China.","volume":"129","author":"Liu","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis.","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/00005072-198811000-00007","article-title":"Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis.","volume":"47","author":"Manetto","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2015.04.032","article-title":"Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis.","volume":"353","author":"McCombe","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1590\/S0100-879X2005000600015","article-title":"Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis.","volume":"38","author":"Mendonca","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3109\/17482968.2010.542002","article-title":"Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?","volume":"12","author":"Mendonca","year":"2011","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jns.2008.04.034","article-title":"Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.","volume":"272","author":"Nalini","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases.","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","article-title":"A specific ELISA for measuring neurofilament heavy chain phosphoforms.","volume":"278","author":"Petzold","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","article-title":"Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.","volume":"85","author":"Puentes","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00415-009-0131-z","article-title":"CSF neurofilament protein analysis in the differential diagnosis of ALS.","volume":"256","author":"Reijn","year":"2009","journal-title":"J. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"issue":"311387","key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311387","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.","volume":"2015","author":"Steinacker","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1046\/j.1471-4159.2001.00094.x","article-title":"Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis.","volume":"76","author":"Strong","year":"2001","journal-title":"J. Neurochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/ene.12421","article-title":"Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.","volume":"22","author":"Tortelli","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/BF00227744","article-title":"Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis.","volume":"84","author":"Troost","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/practneurol-2013-000557","article-title":"Mimics and chameleons in motor neurone disease.","volume":"13","author":"Turner","year":"2013","journal-title":"Pract. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jim.2004.11.015","article-title":"An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.","volume":"296","author":"Van Geel","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"e164625","key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164625","article-title":"Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis.","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2006.06.027","article-title":"Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.","volume":"250","author":"Zoccolella","year":"2006","journal-title":"J. Neurol. Sci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T03:47:33Z","timestamp":1480391253000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2016.00290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":41,"URL":"https:\/\/doi.org\/10.3389\/fnagi.2016.00290","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}